Despite recent advancements, breast cancer continues to be a significant cause of mortality among women worldwide. While mammography has notably reduced mortality rates, accurate classification of breast masses in mammograms remains a challenge. This study proposes a novel approach for the detection of important Regions of Interest (ROIs) and their classification as normal (0), benign (1), or malignant (2) masses. This approach exploits the subtraction of temporally sequential digital mammograms, combined with machine learning. The algorithm was evaluated on a new dataset consisting of 352 images from 88 patients with precisely annotated mass locations. A comprehensive feature extraction process yielded 98 features, which, were subsequently, ranked using eight different feature selection algorithms to identify the most discriminative characteristics. Ten classifiers were evaluated with leave-one-patient-out and k-fold cross-validation. An Artificial Neural Network (ANN) emerged as the most effective classifier, achieving 99.4% overall accuracy, 0.97 AUC for class 0, 0.91 AUC for class 1, and 0.93 AUC for class 2. These results are a significant improvement compared to existing state-of-the-art methods. They also underscore the efficacy of utilizing temporally consecutive mammograms in combination, with advanced machine learning algorithms, for the precise classification of the detected ROIs as normal, benign, or malignant. When clinically applied, the outcome of this study could significantly improve the precision of breast cancer diagnosis, potentially leading to better patient outcomes and more personalized treatment approaches.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/EMBC53108.2024.10781666 | DOI Listing |
Eur J Cancer Prev
March 2025
Department of Oncology and Hemato-Oncology, University of Milan.
Endometriosis is one of the most common gynecological benign disease. Epidemiological evidence suggests a potential association between endometriosis and cancer risk. Accumulating evidence highlighted the risk of ovarian cancer, particularly endometrioid and clear cell subtypes.
View Article and Find Full Text PDFAdv Mater
March 2025
Department of Chemistry, Hanyang University, Seoul, 04763, Republic of Korea.
Migration of implanted self-expandable metallic stent (SEMS) in the malignant or benign esophageal stricture is a common complication but not yet resolved. Herein, this research develops a hydrogel-impregnated robust interlocking nano connector (HiRINC) to ensure adhesion and reduce the mechanical mismatch between SEMSs and esophageal tissues. Featuring a network-like porous layer, HiRINC significantly enhances adhesion and energy dissipation during esophageal peristalsis by utilizing mechanical interlocking and increasing hydrogen bonding sites, thereby securing SEMS to tissues.
View Article and Find Full Text PDFMol Oncol
March 2025
Department of Clinical Science, K.G. Jebsen Center for Genome-Directed Cancer Therapy, University of Bergen, Bergen, Norway.
Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic variants in other genes have also been linked to melanoma, most familial cases remain unexplained. We assessed pathogenic germline variants in 360 cancer-related genes in 56 Norwegian melanoma-prone families.
View Article and Find Full Text PDFJ Magn Reson Imaging
March 2025
Department of Radiology, University of Washington, Seattle, Washington, USA.
Cancer Epidemiol Biomarkers Prev
March 2025
Vanderbilt University Medical Center, Nashville, Tennessee.
Background: The heterogeneous biology of cancer subtypes, especially in lung cancer, poses significant challenges for biomarker development. Standard model building techniques often fall short in accurately incorporating various histologic subtypes because of their diverse biological characteristics. This study explores a nested biomarker model to address this issue, aiming to improve lung cancer early detection.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!